Barclays
SCR

Barclays’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Barclays’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,758
Closed -$97K – 7977
2013
Q4 		$97K Buy
10,758
+4,379
+69% +$41.6K ﹤0.01% 5667
2013
Q3 		$57K Buy
6,379
+3,166
+99% +$30K ﹤0.01% 5989
2013
Q2 		$30K Buy
+3,213
New +$29.7K ﹤0.01% 6637

Barclays's SCR Position: Q1 2014 in Review

Barclays sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 10,758 shares — an estimated $97K sold.

Barclays first reported a position in SCR in Q2 2013 and held it in 3 quarters. The position peaked at $97K in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Barclays reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Barclays sold 10,758 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $97K.
  • Barclays first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 3 quarters.
  • Barclays's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $97K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.